Navigation Links
Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results
Date:3/13/2008

urnal of Palliative Medicine, the official journal of

the American Academy of Palliative Medicine (Thomas JR et al. J Pall

Med. December 2007; 19(6):1312-1320). The authors of this publication

concluded from this volunteer subject study that clinically relevant

fluid volumes can be rapidly delivered subcutaneously with HYLENEX in a

well-tolerated manner without the need for an infusion pump. The

findings suggest that this method of hydration could potentially

replace intravenous infusions in many clinical settings and that

further studies with HYLENEX, in patients, are warranted.

-- The addition to the NASDAQ Biotechnology Index(R) (Nasdaq: NBI) on

November 19, 2007. Launched in 1993, the NASDAQ Biotechnology Index is

ranked on a semi-annual basis in May and November and serves as the

basis for the iShares NASDAQ Biotechnology Fund (Amex: IBB).

Securities included in the NASDAQ Biotechnology Index must be listed on

the NASDAQ National Market and be classified according to the FTSE(TM)

Global Classification System as either biotechnology or pharmaceutical.

Additionally, securities in the index must meet minimum requirements

for market value, average daily share volume and seasoning as a public

company, among other criteria. For more information about the NASDAQ

Biotechnology Index, including eligibility criteria, visit

'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
2. Halozyme Therapeutics to Present at UBS 2007 Global Life Sciences Conference
3. Halozyme Therapeutics Reports 2007 Third Quarter Financial Results
4. Halozyme Therapeutics Amends Stockholder Rights Plan
5. Halozyme Therapeutics to Present at the BIO CEO and Investor Conference and the Roth Growth Stock Conference
6. Halozyme Therapeutics to Hold Pipeline Update Conference Call on March 14
7. Halozyme Therapeutics Presents Favorable New Safety and Pharmacokinetic Data on rHuPH20 Enzyme Produced Via New Manufacturing Process at European Federation for Pharmaceutical Sciences
8. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
9. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
10. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
11. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... -- iVinci Health LLC, the company behind the healthcare industry,s ... as VisitPay®, has successfully closed $5 million in new ... new extension to VisitPay® – an online Payment and ... for patients to manage their medical bills and set-up ... families. The new round of funding, which ...
(Date:9/15/2014)... (PRWEB) September 15, 2014 Applied ... implantable silicones for the medical device and critical ... gel for the implantable medical device market. ... crosslink technology delivering a silicone gel with improved ... Dual Matrix technology consists of two crosslinked networks ...
(Date:9/15/2014)... , 15 de septiembre de 2014 La segunda ... a cabo del 12 al 18 de octubre. Como iniciativa ... y de sus compañías miembro s, la IPAW se ... mundial en torno a la colección de fuentes de plasma ... plasma al salvar y mejorar las vidas , Aumento ...
(Date:9/14/2014)... 2014 UMBC’s Biotechnology Graduate Programs’ ... October 21, 2014, from 12:00 to 1:00 p.m. EDT. ... innovative curriculum and practice-oriented instruction, designed for working professionals. ... help advance their career in the biotechnology industry. , ... , About UMBC’s Biotechnology Graduate Programs, UMBC offers ...
Breaking Biology Technology:iVinci Health Raises $5M to Fuel National Expansion, Announces Launch of Personal Finance Portal for Healthcare 2iVinci Health Raises $5M to Fuel National Expansion, Announces Launch of Personal Finance Portal for Healthcare 3Applied Silicone Launches Silicone Gel System with Dual Matrix Technology 2La International Plasma Awareness Week será una celebración para los donantes 2La International Plasma Awareness Week será una celebración para los donantes 3UMBC Biotechnology Graduate Programs’ Virtual Info Session, October 21, 2014 2
... 3, 2008 In this report,entitled "MedPredict ... physician experts discuss the key controversies,surrounding development ... think the,biopharmaceutical industry is underestimating the size ... physician panel, there are a number of ...
... Calif., April 3, 2008 Ratcliff, the,award-winning architecture, ... new five-story, 380,000-square-foot patient care tower,accompanied by a ... John Muir Medical Center - Walnut Creek Campus. ... Tower that recently broke ground will add,230 private ...
... Campbell Alliance, the,leading management consulting firm specializing in ... Managed Markets Practice will,take a leadership role at ... Modeling Strategies hosted by the Center for Business,Intelligence ... 10 through 11 at,the Doubletree Hotel in Philadelphia, ...
Cached Biology Technology:New MedPredict Report Suggests Market for Alcoholism Therapies is Underestimated 2Ratcliff Designs Hospital of the Future for John Muir Medical Center - Walnut Creek Campus 2Ratcliff Designs Hospital of the Future for John Muir Medical Center - Walnut Creek Campus 3Campbell Alliance Managed Markets Practice to Take a Leadership Role at the CBI Forum on Effective Product Pricing and Modeling Strategies 2Campbell Alliance Managed Markets Practice to Take a Leadership Role at the CBI Forum on Effective Product Pricing and Modeling Strategies 3
(Date:9/15/2014)... cell division has evolved a simple, mechanical solution ... the Sept. 11 Science Express. ... counts and misalignments that lead to infertility, miscarriage, ... cell division cause these problems, but what exactly ... Marston of the Wellcome Trust Center for Cell ...
(Date:9/15/2014)... are produced naturally across all kingdoms of life and ... broad range of biological activities. The presence of halogen ... on their molecular properties. , One of ... find the late-stage, site-specific incorporation of a halogen atom ... C-H bond (one of the most inert chemical bonds ...
(Date:9/15/2014)... results will allow us to better understand how ... change scenarios and provide the type of environmental ... management and siting of protected areas," said Paula ... for Coastal Ocean Science (NCCOS) and lead author ... lie within the temperate-tropical transition zone, where historically, ...
Breaking Biology News(10 mins):Cells simply avoid chromosome confusion 2Cells simply avoid chromosome confusion 3Pitt chemical biologist finds new halogenation enzyme 2Study finds warming Atlantic temperatures could increase range of invasive species 2
... more vulnerable to their environment during embryonic development than ... the University of Glasgow in the UK. Until now, ... unfavorable conditions during the embryonic stage in birds have ... published in Springers journal, Behavioral Ecology and Sociobiology. ...
... gun and storage chest, JERICHO, N.Y., May 6 ... it has added two new products,to its smartTOUCH product ... retailers and online specialty sites., "We are excited ... our,smartTOUCH product line of consumer based finger activated products. ...
... of brain injury, a way to rejuvenate dead nerve ... glaucoma at home, number among this years nine winners ... surprises me every time I walk through this showcase ... many NJIT graduate and undergraduate students, said NJIT Provost ...
Cached Biology News:Seagulls: Are males the weaker sex? 2bioMETRX, Inc. Introduces New Products 2NJIT applauds students for studies on brain injury, glaucoma and more 2
...
Request Info...
... vectors carry the kanamycin resistance gene that ... Spontaneous generation of multiple insertion events can ... of Geneticin Reagent. Pichia transformants are selected ... level of resistance to Geneticin Reagent. The ...
... Synthetic peptide derived from the C-terminal ... Math-2. Specificity: Specific for the ... (positive controls: human U251 A172 IMR-32 ... rat brain homogenates)Storage: Store at -20C ...
Biology Products: